ArticleDiagnostics (Basel, Switzerland)2023

PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors' Response and Survival in Advanced Melanoma Patients in Brazil.

Bruna Pereira Sorroche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.